Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Walter Ángel Trujillo Rangel"'
Autor:
Elodia-Nataly Díaz-de-la-Cruz, Grecia-Elena Hurtado-Nuñez, Sandra-Guadalupe Sánchez-Ceja, Luz Torner, María-Carmen Bartolomé-Camacho, Walter-Ángel Trujillo-Rangel, Martha-Estrella García-Pérez
Publikováno v:
Toxicology Reports, Vol 13, Iss , Pp 101782- (2024)
Methotrexate (MTX) is the most prescribed drug for systemic treatment of psoriasis. However, its clinical use is limited by its nephrotoxicity, which antioxidants can attenuate. This study evaluates the impact of vitamin C (vitC), a well-known antiox
Externí odkaz:
https://doaj.org/article/9d4dfecd27964224a18d0ae599bc15cb
Autor:
Irene Guadalupe Aguilar-García, Jonatan Alpirez, José Francisco Muñoz-Valle, Walter Ángel Trujillo-Rangel, David Fernández-Quezada, Sergio Horacio Dueñas-Jiménez, María de la Luz Galvan-Ramírez, María Guadalupe Sánchez-Parada, Ana Elizabeth González-Santiago, Judith Marcela Dueñas-Jiménez, Rolando Castañeda-Arellano
Publikováno v:
Antioxidants, Vol 13, Iss 11, p 1353 (2024)
Stroke is the third cause of death worldwide and a health problem, and current therapy continues to be very poor. It promotes an alteration associated with excitotoxicity, oxidative stress, and inflammatory processes, exacerbating the damage in the b
Externí odkaz:
https://doaj.org/article/77e212cb62fe4cb890f0ccc62ec8e4c1
Autor:
Walter Ángel Trujillo-Rangel, Leonel García-Valdés, Miriam Méndez-del Villar, Rolando Castañeda-Arellano, Sylvia Elena Totsuka-Sutto, Leonel García-Benavides
Publikováno v:
Oxidative Medicine and Cellular Longevity. 2022:1-25
Ischemia-reperfusion (I-R) injury is damage caused by restoring blood flow into ischemic tissues or organs. This complex and characteristic lesion accelerates cell death induced by signaling pathways such as apoptosis, necrosis, and even ferroptosis.
Autor:
Alejandra Villagómez Vega, Jorge Iván Gámez Nava, Francisco Ruiz González, Misael Pérez Romero, Walter Ángel Trujillo Rangel, Ismael Nuño Arana
Publikováno v:
Genes
Volume 14
Issue 2
Pages: 524
Volume 14
Issue 2
Pages: 524
Background: Postmenopausal osteoporosis is a multifactorial disease. Genetic factors play an essential role in contributing to bone mineral density (BMD) variability, which ranges from 60 to 85%. Alendronate is used as the first line of pharmacologic